Answers are grounded in this paper and cite their sources.
In Brief An update. The development of an inactivated-virus vaccine in 1995 greatly reduced disease burden and changed approaches to primary and secondary prevention of hepatitis A.
No takes yet. Share an insight, caveat, or question.
Catherine Dentinger (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: